NVO Cash from Financing Activities - Cash Flow Statement - Novo Nordisk A/S - IntrinsicAlpha

Novo Nordisk A/S NVO

Healthcare - Drug Manufacturers - General - NYSE - DK

$ 90.65

1.6 %

$ 399 B

Market Cap

28.51

P/E

NVO - CASH FROM FINANCING ACTIVITIES

Cash from Financing Activities NVO - Novo Nordisk A/S

8.74 B

LAST VALUE

47.26%

2 YEAR CAGR

17.57%

5 YEAR CAGR

8.82%

10 YEAR CAGR